期刊
CURRENT TOPICS IN MEDICINAL CHEMISTRY
卷 17, 期 12, 页码 1438-1447出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1568026617666170103162639
关键词
Biomarkers; Genotype; Glioma; Gliomagenesis; Phenotype; Prognosis; Signaling Pathways; Treatment
资金
- University de La Sabana
- Russian Scientific Foundation [14-23-00160]
Gliomas are central nervous system tumors originated from glial cells, whose incidence and mortality is expected to rise in coming years, especially in developing countries. Diagnosis and classification of gliomas have largely relied on tumor histopathologic features that provide limited information regarding response to therapy or prognosis. Current treatment of gliomas is surgery combined with chemotherapy and/or radiotherapy. However, many tumors show a high resistance to these interventions, and recurrences are frequent since conventional therapies do not take into account the unique molecular features of different subtypes of glioma. Molecular genetics provide new insights in classifying gliomas and predicting response to therapy that can range from conventional treatments to new revolutionary therapeutic approaches. This article offers a review of the intracellular signaling pathways involved in carcinogenesis of gliomas, as well as a description of new tools for their diagnosis, prognosis, and treatment with a target-oriented approach.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据